Loading…
Caribou Biosciences, Inc. is projected to rise to $3.52 by 2027, a +52% move from its current price of $2.31. CRBU is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $2.24 | $2.31 | $2.39 | +0.07% |
| May 30 | $2.21 | $2.31 | $2.42 | +0.13% |
| May 31 | $2.19 | $2.31 | $2.45 | +0.20% |
| Jun 1 | $2.17 | $2.32 | $2.47 | +0.26% |
| Jun 2 | $2.16 | $2.32 | $2.49 | +0.33% |
| Jun 3 | $2.14 | $2.32 | $2.51 | +0.39% |
| Jun 4 | $2.13 | $2.32 | $2.53 | +0.46% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.13 | $2.32 | $2.53 | +0.46% |
| Week 2 | $2.07 | $2.33 | $2.63 | +0.92% |
| Week 3 | $2.02 | $2.34 | $2.71 | +1.38% |
| Week 4 | $1.99 | $2.35 | $2.79 | +1.84% |
| Week 5 | $1.96 | $2.36 | $2.86 | +2.31% |
| Week 6 | $1.93 | $2.37 | $2.92 | +2.77% |
| Week 7 | $1.91 | $2.38 | $2.98 | +3.24% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Caribou Biosciences, Inc. operates as a clinical-stage CRISPR genome-editing biopharmaceutical company. It offers a genome-editing platform based on novel CRISPR hybrid RNA-DNA genome-editing technology that enables precise genome editing of allogeneic cell therapies.
Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.
CRBU trades in the Healthcare space with a current price of $2.31. The stock has a market capitalization of $229.11M and is ranked 3706 by market cap. The near-term price outlook aligns with a neutral-to-bullish path, with a 2026 forecast showing an average price of $2.31 and a range from $1.39 to $3.70.
The 2026 view is shown as Neutral in the forecast. Beginning in 2027, the forecast shifts to a bullish stance with rising average prices through 2050.
A major floor 39.8% below — a decisive break under it would weaken the trend.
The nearest floor, 19.0% below — buyers have tended to step in here.
Price is pressing into resistance (2.2% away) — a breakout level to watch.
A major ceiling 15.6% above — clearing it would confirm fresh momentum.
Key CRBU support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CRBU market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.11 | Buy | $2.16 | Buy |
| MA 10 | $2.10 | Buy | $2.11 | Buy |
| MA 20 | $2.02 | Buy | $2.07 | Buy |
| MA 50 | $2.01 | Buy | $2.01 | Buy |
| MA 100 | $1.85 | Buy | $1.94 | Buy |
| MA 200 | $1.94 | Buy | $1.89 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 65.39 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 206.27 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 19.07 | Buy |
| Bollinger %B (20,2) | 1.14 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.10 | Buy |
| Awesome (5,34) | 0.04 | Buy |
| Ultimate (7,14,28) | 65.81 | Neutral |
| Momentum (10) | 0.28 | Buy |
| Aroon Osc (25) | -28.00 | Sell |
| Hull MA (9) | 2.17 | Buy |
| ADX (14) | 12.75 | Neutral |
| ATR (14) | 0.06 | Info |
The 30-day technical picture is bullish. RSI14 sits at 70, signaling strong momentum.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.39 | $2.31 | $3.70 | 0% | Neutral | |
| $2.74 | $3.52 | $4.80 | +52% | Bullish | |
| $2.80 | $3.70 | $5.27 | +60% | Bullish | |
| $3.08 | $4.20 | $6.17 | +82% | Bullish | |
| $3.30 | $4.60 | $6.94 | +99% | Bullish | |
| $3.89 | $5.54 | $8.57 | +140% | Bullish | |
| $4.85 | $7.07 | $11.16 | +206% | Bullish | |
| $5.34 | $7.94 | $12.78 | +244% | Bullish | |
| $5.81 | $8.79 | $14.40 | +280% | Bullish | |
| $5.80 | $8.93 | $14.88 | +287% | Bullish | |
| $9.10 | $15.24 | $27.18 | +560% | Bullish | |
| $18.89 | $36.62 | $72.13 | +14.9x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.39 | $2.31 | $2.74 | +0.00% |
| June 2026 | $2.08 | $2.45 | $2.97 | +6.12% |
| July 2026 | $2.06 | $2.45 | $3.01 | -0.00% |
| August 2026 | $2.07 | $2.48 | $3.09 | +1.29% |
| September 2026 | $2.19 | $2.64 | $3.31 | +6.31% |
| October 2026 | $2.26 | $2.74 | $3.48 | +3.96% |
| November 2026 | $2.26 | $2.76 | $3.52 | +0.55% |
| December 2026 | $2.34 | $2.88 | $3.70 | +4.23% |
Click any year to see its month-by-month CRBU forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The CRBU price prediction for 2026 points to an average of $2.31 (low $1.39, high $3.70) — a potential gain of 0% on today's $2.31. A consolidation phase looks the most probable path here.
In 2027, CRBU is projected to trade between $2.74 and $4.80, averaging $3.52 — a potential gain of +52% from today's $2.31. That is up +52% on the projected 2026 average. Momentum favours further upside here.
Caribou Biosciences, Inc.'s 2028 outlook centres on $3.70, within a $2.80 to $5.27 range. That is up +5% on the projected 2027 average. That marks a +60% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, CRBU could reach as high as $6.17, with a base case around $4.20 and support toward $3.08 — roughly +82% from $2.31. Momentum favours further upside here.
Expect CRBU to range from $3.30 to $6.94 through 2030. The $4.60 average target implies a +99% move from current prices. That is up +10% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The CRBU price prediction for 2031 points to an average of $5.54 (low $3.89, high $8.57) — a potential gain of +140% on today's $2.31. Momentum favours further upside here.
In 2032, CRBU is projected to trade between $4.85 and $11.16, averaging $7.07 — a potential gain of +206% from today's $2.31. That is up +27% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Caribou Biosciences, Inc.'s 2033 outlook centres on $7.94, within a $5.34 to $12.78 range. That is up +12% on the projected 2032 average. That marks a +244% change versus current levels. Momentum favours further upside here.
By 2034, CRBU could reach as high as $14.40, with a base case around $8.79 and support toward $5.81 — roughly +280% from $2.31. Buyers look set to stay in control over this stretch.
Expect CRBU to range from $5.80 to $14.88 through 2035. The $8.93 average target implies a +287% move from current prices. That is up +2% on the projected 2034 average. Momentum favours further upside here.
The CRBU price prediction for 2040 points to an average of $15.24 (low $9.10, high $27.18) — a potential gain of +560% on today's $2.31. Buyers look set to stay in control over this stretch.
In 2050, CRBU is projected to trade between $18.89 and $72.13, averaging $36.62 — a potential gain of +14.9x from today's $2.31. That is up +140% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in CRBU today (≈ 432.900433 CRBU) could be worth
$15,852.26
+$14,852.26 (+1485%) by 2050 · US Dollar
Based on the average projected CRBU price of $36.62 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CRBUwould be worth at today's price.
$1,000 invested in CRBU on May 27, 2025 (≈ 917.431165 CRBU) would be worth
$2,119.27
+$1,119.27 (+111.9%) today · 2.12× · US Dollar
Based on a CRBU entry price of $1.09 vs. today's $2.31.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2 | $1,155 | +15.5% |
| 1 month ago | $2.13 | $1,084.51 | +8.5% |
| 3 months ago | $1.99 | $1,160.8 | +16.1% |
| 6 months ago | $1.94 | $1,190.72 | +19.1% |
| 1 year ago | $1.09 | $2,119.27 | +111.9% |
| All time (4.8y) ago | $16.32 | $141.54 | -85.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CRBU forecast.
Our base-case forecast reaches $4.60 around 2031.
Implied market cap at $4.60: $456.23M
By 2030 the forecast shows an average price of $4.60 with a min of $3.30 and a max of $6.94, and a bullish sentiment. The implied return hits 99% in this year’s outlook. By 2040 the average price is projected at $15.24, with a min of $9.10 and a max of $27.18, a bullish sentiment and a strong 559.6% ROI.
By 2050 the forecast envisions an average price of $36.62, a min of $18.89 and a max of $72.13, with a bullish sentiment and an ROI of 1485.2%. These long-range figures imply substantial upside from the current price, but they remain estimates and carry uncertainty.
Tap a question to reveal the answer.
2030 Avg $4.60, Min $3.30, Max $6.94; ROI 99; sentiment BULLISH.
The forecast shows bullish sentiment from 2027 onward with rising averages (e.g., 2027 Avg $3.52, 2028 Avg $3.70, 2029 Avg $4.20) and positive ROIs (52.2% in 2027, 60.3% in 2028, 81.7% in 2029). The 2026 view is Neutral. These are estimates and not guarantees.
Yes. The forecast max reaches above $10 by 2032 (2032 Max $11.16). The trajectory continues higher in later years (2040 Max $27.18, 2050 Max $72.13).
Current price: $2.31; Market cap: $229.11M.
Sentiment: BULLISH. RSI14: 70. SMA50: $2.01; SMA200: $1.94. Support: $1.87; Resistance: $2.36. The 30-day range runs from $1.87 to $2.85. Annualized volatility: 60%.
Caribou Biosciences, Inc. Community Discussion
0Share your Caribou Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.